文献速递白血病

NPM1c改变FLT3-D835Y定位与信号传导

NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia.
PubMed 文献 · Blood · 2019-06-11

研究探讨了NPM1c与FLT3-TKD共突变在AML中的作用机制。小鼠中单独表达FLT3-TKD不足以致病,但与NPM1c共表达后31.5天即快速发生侵袭性骨髓增殖性疾病。NPM1c使FLT3-TKD从细胞表面转位至内质网,仅在NPM1c存在时FLT3-TKD激活STAT5,该现象在共突变AML患者原代细胞中亦存在。

要点

  • NPM1c与FLT3-TKD共表达在小鼠中31.5天即诱导侵袭性骨髓增殖性疾病。
  • FLT3-TKD仅在NPM1c存在时激活下游STAT5。
  • NPM1c使FLT3-TKD从细胞表面转位至内质网。

核心结论

  • NPM1c通过改变FLT3-TKD的细胞定位并改变其信号传导能力,为NPM1突变状态对FLT3-TKD点突变患者的强预后相关性提供了生物学机制解释。

研究设计与样本

  • 在小鼠模型中研究NPM1c与FLT3-TKD共表达的作用,并在共突变AML患者原代细胞中验证。

主要发现

  • 单独表达FLT3-TKD不足以在小鼠中诱导疾病,与NPM1c共表达后31.5天即发生侵袭性骨髓增殖性疾病。
  • FLT3-TKD仅在突变型NPM1c存在时激活下游效应分子STAT5。
  • NPM1c使FLT3-TKD从细胞表面转位至内质网,可能由此导致STAT5异常激活。
  • 异常STAT5激活不仅见于小鼠原代细胞,也见于携带FLT3-TKD与NPM1c共突变的AML患者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Activating mutations in FMS-like tyrosine kinase receptor-3 (FLT3) and Nucleophosmin-1 (NPM1) are most frequent alterations in acute myeloid leukemia (AML), and are often coincidental. The mutational status of NPM1 has strong prognostic relevance to patients with point mutations of the FLT3 tyrosine kinase domain (TKD), but the biological mechanism underlying this effect remains unclear. In the present study, we investigated the effect of the coincidence of NPM1c and FLT3-TKD. Although expression of FLT3-TKD is not sufficient to induce a disease in mice, coexpression with NPM1c rapidly leads to an aggressive myeloproliferative disease in mice with a latency of 31.5 days. Mechanistically, we could show that FLT3-TKD is able to activate the downstream effector molecule signal transducer and activator of transcription 5 (STAT5) exclusively in the presence of mutated NPM1c. Moreover, NPM1c alters the cellular localization of FLT3-TKD from the cell surface to the endoplasmic reticulum, which might thereby lead to the aberrant STAT5 activation. Importantly, aberrant STAT5 activation occurs not only in primary murine cells but also in patients with AML with combined FLT3-TKD and NPM1c mutations. Thus, our data indicate a new mechanism, how NPM1c mislocalizes FLT3-TKD and changes its signal transduction ability.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Rudorf A, Müller TA, Klingeberg C, et al. NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia. Blood. 2019. PMID: 31186273. doi:10.1182/blood.2018883140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。